These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 21986389)

  • 1. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.
    Manson JE; Bassuk SS; Lee IM; Cook NR; Albert MA; Gordon D; Zaharris E; Macfadyen JG; Danielson E; Lin J; Zhang SM; Buring JE
    Contemp Clin Trials; 2012 Jan; 33(1):159-71. PubMed ID: 21986389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung VITAL: Rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adults.
    Gold DR; Litonjua AA; Carey VJ; Manson JE; Buring JE; Lee IM; Gordon D; Walter J; Friedenberg G; Hankinson JL; Copeland T; Luttmann-Gibson H
    Contemp Clin Trials; 2016 Mar; 47():185-95. PubMed ID: 26784651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL).
    Bassuk SS; Manson JE; Lee IM; Cook NR; Christen WG; Bubes VY; Gordon DS; Copeland T; Friedenberg G; D'Agostino DM; Ridge CY; MacFadyen JG; Kalan K; Buring JE
    Contemp Clin Trials; 2016 Mar; 47():235-43. PubMed ID: 26767629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depression.
    Okereke OI; Reynolds CF; Mischoulon D; Chang G; Cook NR; Copeland T; Friedenberg G; Buring JE; Manson JE
    Contemp Clin Trials; 2018 May; 68():133-145. PubMed ID: 29526608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence.
    Manson JE; Bassuk SS; Cook NR; Lee IM; Mora S; Albert CM; Buring JE;
    Circ Res; 2020 Jan; 126(1):112-128. PubMed ID: 31895658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the Vitamin D and OmegA-3 trial (VITAL).
    Pradhan AD; Manson JE
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):252-6. PubMed ID: 25864623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial.
    Hahn J; Cook NR; Alexander EK; Friedman S; Walter J; Bubes V; Kotler G; Lee IM; Manson JE; Costenbader KH
    BMJ; 2022 Jan; 376():e066452. PubMed ID: 35082139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL): Effects on Bone Structure and Architecture.
    Donlon CM; LeBoff MS; Chou SH; Cook NR; Copeland T; Buring JE; Bubes V; Kotler G; Manson JE
    Contemp Clin Trials; 2018 Apr; 67():56-67. PubMed ID: 29408561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Vitamin D and ω-3 Fatty Acid Supplementation on Risk of Age-Related Macular Degeneration: An Ancillary Study of the VITAL Randomized Clinical Trial.
    Christen WG; Cook NR; Manson JE; Buring JE; Chasman DI; Lee IM; Bubes V; Li C; Haubourg M; Schaumberg DA;
    JAMA Ophthalmol; 2020 Dec; 138(12):1280-1289. PubMed ID: 33119047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial.
    Albert CM; Cook NR; Pester J; Moorthy MV; Ridge C; Danik JS; Gencer B; Siddiqi HK; Ng C; Gibson H; Mora S; Buring JE; Manson JE
    JAMA; 2021 Mar; 325(11):1061-1073. PubMed ID: 33724323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Marine ω-3 Fatty Acid Supplementation vs Placebo in Reducing Incidence of Dry Eye Disease in Healthy US Adults: A Randomized Clinical Trial.
    Christen WG; Cook NR; Manson JE; Buring JE; Lee IM; Bubes V; Friedenberg G; Dushkes R; Smith D; Schaumberg DA;
    JAMA Ophthalmol; 2022 Jul; 140(7):707-714. PubMed ID: 35679030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D, Omega-3 Fatty Acids Don't Lower Rates of Cancer or CVD.
    Zolot J
    Am J Nurs; 2019 Feb; 119(2):15. PubMed ID: 30681467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VITamin D and OmegA-3 TriaL (VITAL): Effects of Vitamin D Supplements on Risk of Falls in the US Population.
    LeBoff MS; Murata EM; Cook NR; Cawthon P; Chou SH; Kotler G; Bubes V; Buring JE; Manson JE
    J Clin Endocrinol Metab; 2020 Sep; 105(9):2929-38. PubMed ID: 32492153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of co supplementation of omega-3 and vitamin D on cardio metabolic risk factors and psychological distress in reproductive-aged women with prediabetes and hypovitaminosis D: a study protocol for a randomized controlled trial.
    Rajabi-Naeeni M; Dolatian M; Qorbani M; Vaezi AA
    Trials; 2019 Dec; 20(1):799. PubMed ID: 31888762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VITAL-Bone Health: rationale and design of two ancillary studies evaluating the effects of vitamin D and/or omega-3 fatty acid supplements on incident fractures and bone health outcomes in the VITamin D and OmegA-3 TriaL (VITAL).
    LeBoff MS; Yue AY; Copeland T; Cook NR; Buring JE; Manson JE
    Contemp Clin Trials; 2015 Mar; 41():259-68. PubMed ID: 25623291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D and omega-3 trial to prevent and treat diabetic kidney disease: Rationale, design, and baseline characteristics.
    de Boer IH; Zelnick LR; Lin J; Schaumberg D; Wang L; Ruzinski J; Friedenberg G; Duszlak J; Bubes VY; Hoofnagle AN; Thadhani R; Glynn RJ; Buring JE; Sesso HD; Manson JE
    Contemp Clin Trials; 2018 Nov; 74():11-17. PubMed ID: 30282055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.
    Okereke OI; Vyas CM; Mischoulon D; Chang G; Cook NR; Weinberg A; Bubes V; Copeland T; Friedenberg G; Lee IM; Buring JE; Reynolds CF; Manson JE
    JAMA; 2021 Dec; 326(23):2385-2394. PubMed ID: 34932079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
    Hobbs T; Caso R; McMahon D; Nymark M
    Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D and omega-3 fatty acid supplements in children with autism spectrum disorder: a study protocol for a factorial randomised, double-blind, placebo-controlled trial.
    Mazahery H; Conlon C; Beck KL; Kruger MC; Stonehouse W; Camargo CA; Meyer BJ; Tsang B; Mugridge O; von Hurst PR
    Trials; 2016 Jun; 17(1):295. PubMed ID: 27334138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.